Drug
Triptorelin (GnRH agonists)
Triptorelin (GnRH agonists) is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_4
2
67%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
unknown1
Enrolling by invitation1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 42 (66.7%)
N/A1 (33.3%)
Trials by Status
unknown133%
enrolling_by_invitation133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_4
Ultra-Long GnRH-a Pretreatment for FET Outcomes in Patients With Deep Infiltrating Endometriosis
NCT07696351
enrolling_by_invitationnot_applicable
Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism
NCT06691815
unknownphase_4
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
NCT00438217
Clinical Trials (3)
Showing 3 of 3 trials
NCT07696351Phase 4
Ultra-Long GnRH-a Pretreatment for FET Outcomes in Patients With Deep Infiltrating Endometriosis
NCT06691815Not Applicable
Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism
NCT00438217Phase 4
Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3